Comparison of retroperitoneoscopic adrenalectomy versus transperitoneal laparoscopic adrenalectomy: Are they both equally safe? A university center experience
Thomas Prudhomme(Société Francophone du Diabète), É. Huyghe(Université Toulouse III - Paul Sabatier), Delphine Vezzosi(Université Toulouse III - Paul Sabatier), M. Roumiguié(Institut universitaire du cancer de Toulouse Oncopole), J. Gas(Hôpital Rangueil), B Chamontin(Inserm), Béatrice Bouhanick(Hôpital Rangueil), J. Amar, G. Crenn(Hôpital Rangueil), M. Soulié(Hôpital Rangueil), M. Thoulouzan(Hôpital Rangueil), A. Bennet, A. Gryn(Hôpital Rangueil), Philippe Caron(Hôpital Larrey)
Cited by 0
Related Papers
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome
|New England Journal of Medicine|2014|434
Ketoconazole in Cushing's Disease: Is It Worth a Try?
|The Journal of Clinical Endocrinology & Metabolism|2014|288